Safety and Feasibility Evaluation of the APS APP

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 28, 2018

Primary Completion Date

September 4, 2018

Study Completion Date

September 4, 2018

Conditions
Type 1 Diabetes Mellitus
Interventions
DEVICE

Artificial Pancreas App

The portable Artificial Pancreas System App (APS APP) is an artificial pancreas system comprised primarily of an insulin pump, a continuous glucose monitor (CGM), and a cellular phone device to connect the components.

Trial Locations (1)

93105

Sansum Diabetes Research Institute, Santa Barbara

All Listed Sponsors
collaborator

Harvard University

OTHER

lead

Sansum Diabetes Research Institute

OTHER